Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 3—March 2021
Research

Epidemiology and Clinical Course of First Wave Coronavirus Disease Cases, Faroe Islands

Marnar F. KristiansenComments to Author , Bodil H. Heimustovu, Sanna á Borg, Tróndur Høgnason Mohr, Hannes Gislason, Lars Fodgaard Møller, Debes H. Christiansen, Bjarni á Steig, Maria Skaalum Petersen, Marin Strøm, and Shahin Gaini
Author affiliations: National Hospital of the Faroe Islands, Tórshavn, Faroe Islands (M.F. Kristiansen, B.H. Heimustovu, S. á Borg, T.H. Mohr, B. á Steig, S. Gaini); Ministry of Health COVID-19 Task Force, Tórshavn (M.F. Kristiansen, B.H. Heimustovu, B. á Steig); University of the Faroe Islands, Tórshavn (M.F. Kristiansen, H. Gislason, M.S. Petersen, M. Strøm, S. Gaini); Office of the Chief Medical Officer, Tórshavn (L.F. Møller); Faroese Food and Veterinary Authority, Tórshavn (D.H. Christiansen); The Faroese Hospital System, Tórshavn (M.S. Petersen); Statens Serum Institut, Copenhagen, Denmark (M. Strøm); Odense University Hospital, Odense, Denmark (S. Gaini); University of Southern Denmark, Odense (S. Gaini)

Main Article

Table

Occurrence, characteristics, and symptoms of 187 coronavirus disease cases during March 3–May 8, 2020, Faroe Islands*

Variable COVID-19 cases
All cases Sex
 Age range, y
Male Female 0–17 18–64 >65
All cases 187 88 (47.1) 99 (52.9) 24 (12.8) 143 (76.5) 20 (10.7)
Cases/100,000 population 357 324 393 184 478 218
Cases tested by RT-PCR 6,957 3,091 (45.5) 3,866 (54.5) 1,132 (19.3) 4,965 (68.4) 860 (12.3)
RT-PCR tests/100,000 population
 13,339
 11,377
 15,305
8,660
 16,597
 9,381
Reported symptoms
Asymptomatic 21 (11.2) 11 (12.5) 10 (10.1) 6 (25.0) 9 (6.3) 6 (30.0)
Fever 118 (63.1) 55 (62.5) 63 (63.6) 12 (50.0) 94 (65.7) 12 (60.0)
Cough 83 (44.4) 47 (53.4) 36 (36.4) 4 (16.7) 71 (49.7) 8 (40.0)
Headache 89 (47.6) 36 (40.9) 53 (53.5) 5 (20.8) 78 (54.5) 6 (30.0)
Sore throat 56 (29.9) 24 (27.3) 32 (32.3) 3 (12.5) 51 (35,7) 2 (10.0)
Dyspnea 20 (10.7) 7 (8.0) 13 (13.1) 1 (4.2) 19 (13.3) 0 (0.0)
Loss of smell or taste† 63 (33.7) 23 (26.1) 40 (40.4) 3 (12.5) 56 (39.2) 4 (20.0)
Fatigue† 26 (13.9) 11 (12.5) 15 (15.2) 0 (0.0) 23 (16.1) 3 (15.0)
Rhinorrhea† 44 (23.5) 21 (23.9) 23 (23.2) 4 (16.7) 35 (24.5) 5 (25.0)
Body aches† 36 (19.3) 22 (25.0) 14 (14.1) 1 (4.2) 30 (21) 5 (25.0)
Chest tightness† 15 (8.0) 8 (9.1) 7 (7.1) 1 (4.2) 14 (9.8) 0 (0.0)
Diarrhea† 11 (5.9) 2 (2.3) 9 (9.1) 2 (8.3) 6 (4.2) 3 (15.0)
Abdominal pain† 11 (5.9) 4 (4.5) 7 (7.1) 3 (12.5) 4 (2.8) 4 (20.0)

*Values are no. (%) except as indicated. COVID-19, coronavirus disease; RT-PCR, reverse transcription PCR.
†Only recorded when mentioned by patients. Other symptoms were systematically collected.

Main Article

Page created: January 07, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external